Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation

NCT07205289 is registered in ClinicalTrials.gov with GPN Vaccines as lead sponsor.

NCT NCT07205289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07205289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation
Lead sponsor
GPN Vaccines
Phase
Phase 1
Overall status
Recruiting
Start date
October 31, 2025
Completion date
June 30, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal disease, pneumococcal disease, invasive